Clinerion global network in Greece
Press release: The Hygeia Group of hospitals expands Clinerion’s global network of hospitals into Greece.
Publication date: August 08, 2018
The Hygeia Group, comprising three hospitals in Athens, Greece, joins Clinerion’s hospital global network and expands Clinerion’s Patient Network Explorer footprint in Europe.
The Hygeia Group comprises three hospitals:
- the Hygeia hospital, a diagnostic and therapeutic center and general hospital in Athens, Greece with 315 beds;
- the Mitera Hospital, a general hospital specializing in maternity, gynecology and children’s health in Athens, Greece with 459 beds;
- the Leto Hospital, a maternity and gynecology hospital, and surgical center in Athens, Greece with 100 beds.
The Hygeia Hospital is the only hospital in Greece with a Joint Commission International (JCI) Gold Seal accreditation for quality and safety in healthcare. The group currently conducts over 80 clinical trials per year.
Download the PDF for the full release: The Hygeia Group of hospitals expands Clinerion global network
The Hygeia Hospital
The Hygeia Hospital is the only hospital in Greece with a Joint Commission International (JCI) Gold Seal accreditation for quality and safety in healthcare. The group currently conducts over 80 clinical trials per year.
Joining Clinerion’s Patient Network Explorer platform will bring more innovative treatments to the patients of the Hygeia Group’s hospitals and clinics, and give their physicians more options in treating their patients. The group will also gain more exposure to global clinical trials run by international pharmaceutical companies and contract research organizations. Drug developers working on innovative treatments will now benefit from access to these new geographies and clinics with strong therapeutic focus.
“The strong oncology orientation of our hospitals along with the high-quality oncology staff provide a great opportunity to all stakeholders to enhance clinical trials with novel agents and combinations for our patients’ benefit,” says Mr. Andreas Kartapanis, CEO of the Hygeia Group. “The Hygeia Group has state-of-the-art infrastructure and equipment, and a roster of expert clinicians,” says Ian Rentsch, CEO of Clinerion. “This will be a great benefit to pharma companies and CROs looking to accelerate their drug trials in Greece.”
About Clinerion
Clinerion enables early patient access to innovative treatments through real-patient data solutions for clinical trial patient recruitment, real-world evidence, and market access. Clinerion’s Patient Network Explorer accelerates clinical research by radically improving the efficiency and effectiveness of trial recruitment.
Clinerion’s key patient data services include data-driven protocol optimization, site feasibility evaluation and patient identification. Clinerion’s solutions allow member hospitals to participate in leading-edge, industry-sponsored trials and save time in patient recruitment. They enable pharmaceutical companies to gain time and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which remain under the full control of participating hospitals. Clinerion is a global data technology service company headquartered in Switzerland. Clinerion’s solutions comply with international patient privacy and data security regulations.
Clinerion website: www.clinerion.com
Clinerion’s Patient Network Explorer:
www.clinerion.com/index/OverviewOurSolutions/Clineriontechnologysolution
For more information, please contact:
Le Vin Chin
Head of Marketing and Communications
Clinerion Ltd
Margarethenstrasse 47, CH-4053 Basel, Switzerland
Tel.: +41 61 865 60 54
media@clinerion.com
